8-K: Body and Mind Inc. Reports Q2 Fiscal 2024 Results, Net Loss Improves Significantly

Body and Mind Inc. announced its Q2 fiscal year 2024 results, showing a significant reduction in net loss and improved gross margins despite flat revenue compared to the same quarter last year.

Summary

• Body and Mind Inc. reported a revenue of $4.4 million for the second quarter of fiscal year 2024, which is the same as the revenue for the second quarter of fiscal year 2023.
• The company's net loss significantly improved to $0.2 million in Q2 FY2024, compared to a net loss of $2.7 million in Q2 FY2023.
• Gross margin increased to 45.7% in Q2 FY2024, up from 39.9% in Q1 FY2023.
• The company had 147,686,393 common shares outstanding as of March 25, 2024.
• Body and Mind has entered into an agreement to sell its Nevada cultivation and production operations for $2 million to focus on higher-return projects in Illinois and New Jersey.
• The company is progressing with its New Jersey dispensary license application, with demolition complete and a building permit expected soon.
• Construction of the Lynwood, Illinois dispensary is nearing completion, with an expected opening in the first half of calendar year 2024.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the significant improvement in net loss and gross margin, despite flat revenue. The strategic focus on Illinois and New Jersey is also viewed favorably.

Positives

• The company significantly reduced its net loss from $2.7 million to $0.2 million year-over-year.
• Gross margins improved to 45.7%, indicating better operational efficiency.
• The divestiture of the Nevada operations will allow the company to focus on more profitable markets.
• The company is making progress on its New Jersey dispensary license and the Lynwood, Illinois dispensary construction.

Negatives

• Revenue remained flat year-over-year at $4.4 million.
• The company is still reporting a net loss, although significantly reduced.

Risks

• The company's future performance is dependent on the successful launch of new dispensaries in Illinois and New Jersey.
• The cannabis industry is subject to regulatory changes and market fluctuations.
• The company's ability to achieve profitability in the long term is not guaranteed.

Future Outlook

The company is focused on expanding its operations in Illinois and New Jersey, with the expectation that these markets will provide significant revenue growth opportunities. The Lynwood, Illinois dispensary is expected to open in the first half of calendar 2024.

Management Comments

• The most recent quarter reflects our work to improve financial performance, improve margins and streamline our operations to support building our operations in Illinois and New Jersey, stated Michael Mills, CEO of Body and Mind.
• Nevadas wholesale pricing challenges and wholesale tax structure made it difficult to see the Companys Nevada operations generating sufficient profits over the long term when compared with the opportunity presented by taking the proceeds from Nevadas sale and continuing to build on our Illinois and New Jersey opportunities.
• We feel the Illinois and New Jersey markets continue to be underserved and offer significant opportunities for revenue growth as we expand our brand and bring our skilled teams to these new markets.

Industry Context

The announcement reflects a trend in the cannabis industry where companies are focusing on high-growth markets and divesting from less profitable operations. The focus on Illinois and New Jersey aligns with the increasing legalization and market potential in these states.

Comparison to Industry Standards

• While revenue remained flat year-over-year, the significant improvement in net loss and gross margin suggests that Body and Mind is making progress in operational efficiency.
• Compared to other multi-state cannabis operators, the focus on specific high-growth markets like Illinois and New Jersey is a common strategy to maximize returns.
• Companies like Curaleaf and Green Thumb Industries have also been focusing on expanding their retail footprint in key states, indicating a similar strategic approach.
• The divestiture of Nevada operations is similar to other companies streamlining their portfolios to focus on core markets.

Stakeholder Impact

• Shareholders will likely view the improved financial performance and strategic focus positively.
• Employees in Illinois and New Jersey may see increased opportunities as the company expands in those markets.
• Customers in Illinois and New Jersey will have access to new retail locations.
• The divestiture of Nevada operations may impact employees and suppliers in that region.

Next Steps

• The company will continue to advance its New Jersey dispensary license application.
• The company will complete construction and open the Lynwood, Illinois dispensary in the first half of calendar 2024.
• The company will focus on expanding its brand and operations in Illinois and New Jersey.

Key Dates

Keywords

cannabis, financial results, dispensary, net loss, gross margin, revenue, Illinois, New Jersey, divestiture, operations